STEM-PD Open Label Extension (OLE)

NATerminatedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

September 15, 2022

Primary Completion Date

February 24, 2025

Study Completion Date

February 24, 2025

Conditions
Parkinson DiseaseParkinson's Disease and Parkinsonism
Interventions
DEVICE

Open Label Extension Study

This study will investigate the safety and efficacy of extended treatments for the management of symptoms related to PD.

Trial Locations (15)

23601

Riverside Neurology Specialists, Newport News

27607

Meridian Clinical Research, Raleigh

29425

Medical University of South Carolina, Charleston

32819

Headlands Research Orlando, Orlando

33486

Parkinson's Disease and Movement Disorder of Boca Raton, Boca Raton

33613

University of South Florida, Tampa

38157

Veracity Neuroscience, Memphis

44195

Cleveland Clinic, Cleveland

48334

Quest Research, Farmington Hills

49503

Mercy Health Saint Mary's, Grand Rapids

66160

University of Kansas Medical Center - Parkinson's Disease Center, Kansas City

77030

Houston Methodist Neurological Institute, Houston

85258

Movement Disorder Center of Arizona, Scottsdale

87131

University of New Mexico, Albuquerque

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Scion NeuroStim

INDUSTRY